Alpha2 Agonist Use in Critically Ill Adults: A Focus on Sedation and Withdrawal Prevention.

clonidine dexmedetomidine guanfacine sedation withdrawal

Journal

Journal of pharmacy practice
ISSN: 1531-1937
Titre abrégé: J Pharm Pract
Pays: United States
ID NLM: 8900945

Informations de publication

Date de publication:
21 Jun 2024
Historique:
medline: 22 6 2024
pubmed: 22 6 2024
entrez: 22 6 2024
Statut: aheadofprint

Résumé

The management of sedation in critically ill adults poses a unique challenge to clinicians. Dexmedetomidine, an α

Identifiants

pubmed: 38907529
doi: 10.1177/08971900241263171
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

8971900241263171

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Ashley Schuler (A)

Department of Pharmacy, Ohio Health Riverside Methodist Hospital, Columbus, OH, USA.

Connie H Yoon (CH)

Department of Pharmacy, Ohio Health Riverside Methodist Hospital, Columbus, OH, USA.

Erica Caffarini (E)

Department of Pharmacy, Ohio Health Riverside Methodist Hospital, Columbus, OH, USA.

Alexander Heine (A)

Department of Pharmacy, Ohio Health Riverside Methodist Hospital, Columbus, OH, USA.

Alyssa Meester (A)

Department of Pharmacy, Ohio Health Riverside Methodist Hospital, Columbus, OH, USA.

Danielle Murray (D)

Department of Pharmacy, Ohio Health Riverside Methodist Hospital, Columbus, OH, USA.

Angela Harding (A)

Department of Pharmacy, Ohio Health Riverside Methodist Hospital, Columbus, OH, USA.

Classifications MeSH